These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 28692637

  • 1. Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease.
    de Souza JMQ, Braga A, Sanches Dos Santos R, Ramos MM, Cortés-Charry R, Maestá I.
    Int J Gynecol Cancer; 2017 Sep; 27(7):1494-1500. PubMed ID: 28692637
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
    Matsui H, Kihara M, Usui H, Tate S, Mitsuhashi A, Shozu M.
    J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
    [Abstract] [Full Text] [Related]

  • 3. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn E.
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [Abstract] [Full Text] [Related]

  • 4. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MG.
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [Abstract] [Full Text] [Related]

  • 5. Correlation levels of serum placental growth factor and human chorionic gonadotropin in gestational trophoblastic disease patients.
    Oranratanaphan S, Wongwathanavikrom R, Lertkhachonsuk R.
    J Reprod Med; 2011 Nov; 56(7-8):333-8. PubMed ID: 21838164
    [Abstract] [Full Text] [Related]

  • 6. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
    Lybol C, Sweep FC, Ottevanger PB, Massuger LF, Thomas CM.
    Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM.
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [Abstract] [Full Text] [Related]

  • 8. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C, Doret M, Massardier J, Hajri T, Schott AM, Raudrant D, Golfier F.
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [Abstract] [Full Text] [Related]

  • 9. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A, Maestá I, Short D, Savage P, Harvey R, Seckl MJ.
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [Abstract] [Full Text] [Related]

  • 10. A Novel Prediction Model for Postmolar Gestational Trophoblastic Neoplasia and Comparison With Existing Models.
    Zhao P, Wang S, Zhang X, Lu W.
    Int J Gynecol Cancer; 2017 Jun; 27(5):1028-1034. PubMed ID: 28498254
    [Abstract] [Full Text] [Related]

  • 11. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
    Eysbouts Y, Brouwer R, Ottevanger P, Massuger L, Sweep F, Thomas C, van Herwaarden A.
    Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
    [Abstract] [Full Text] [Related]

  • 12. Quantitative urine hCG and urine pregnancy test in gestational trophoblastic disease patients with low hCG titer.
    Lertkhachonsuk R.
    J Med Assoc Thai; 2015 Jan; 98 Suppl 1():S36-41. PubMed ID: 25764611
    [Abstract] [Full Text] [Related]

  • 13. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M, Kane-Gueye SM, Ndiaye-Gueye MD, Mbaye M, Diouf AA, Niang MM, Diallo M, Moreau JC.
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [Abstract] [Full Text] [Related]

  • 14. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
    Bakhtiyari M, Mirzamoradi M, Kimyaiee P, Aghaie A, Mansournia MA, Ashrafi-Vand S, Sarfjoo FS.
    Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
    [Abstract] [Full Text] [Related]

  • 15. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A, Biscaro A, do Amaral Giordani JM, Viggiano M, Elias KM, Berkowitz RS, Seckl MJ.
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [Abstract] [Full Text] [Related]

  • 16. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CY, Seckl MJ, Kohorn EI.
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [Abstract] [Full Text] [Related]

  • 17. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [Abstract] [Full Text] [Related]

  • 18. Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?
    Delattre S, Han S, Moerman P, Billen J, Goffin F, Scharpé K, Vergote I.
    Gynecol Obstet Invest; 2018 Jan; 83(1):76-82. PubMed ID: 28329740
    [Abstract] [Full Text] [Related]

  • 19. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
    Kang WD, Choi HS, Kim SM.
    Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
    [Abstract] [Full Text] [Related]

  • 20. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I, Vejerslev LO, Frøding L, Blaakær J, Maroun LL, Hansen ES, Grove A, Lund H, Havsteen H, Sunde L.
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.